Target intelligence / Profile preview

Novel transcript, antisense to RPL3L (ENSG00000295233)

Target: ENSG00000295233
Molecular classification: Other

Overview

ENSG00000295233 encodes a novel, uncharacterized, non-coding RNA molecule that is antisense to the ribosomal protein L3-like gene (RPL3L). The RPL3L gene is a tissue-specific component of the ribosome found in heart and skeletal muscle, involved in muscle function and implicated in certain cardiomyopathies[3]. However, the antisense transcript has not been shown to encode a protein or to have a distinct biological function, and its role (if any) in gene regulation or disease has not been established in the literature or genome databases to date[5].

Other names: novel transcript, antisense to RPL3L

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on Novel transcript, antisense to RPL3L (ENSG00000295233).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to RPL3L (ENSG00000295233).

Explore the full profile